Who owns XYNPW - XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202 based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202 (XYNPW) Institutional Ownership

Q: What is CUSIP 98421X110?

CUSIP 98421X110 is the security identifier used in SEC filing datasets for XYNPW - XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202.

CUSIP: 98421X110

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2019

Type / Class: Equity / *W EXP 05/15/202
Symbol: XYNPW

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 98421X110?
CUSIP 98421X110 identifies XYNPW - XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202 in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 98421X110:

Q4 2019 (0 holders) Q3 2019 (1 holder) Q2 2019 (12 holders)

Institutional Holders of XYNOMIC PHARMACUTCLS HLDNG I - *W EXP 05/15/202 (XYNPW) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2019 Q4	0	$0	-$5,000		0
2019 Q3	63,000	$5,000	-$171,000	$0.08	1
2019 Q2	923,368	$195,000	+$195,000	$0.21	12